Bill Text: IL SR0233 | 2021-2022 | 102nd General Assembly | Introduced
Bill Title: Declares the week of May 2, 2021 as "Tardive Dyskinesia Awareness Week" and encourages every individual in the United States to become better informed about the disease.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2021-04-23 - Referred to Assignments [SR0233 Detail]
Download: Illinois-2021-SR0233-Introduced.html
| |||||||
| |||||||
| |||||||
| 1 | SENATE RESOLUTION
| ||||||
| 2 | WHEREAS, Many peoples with serious, chronic mental | ||||||
| 3 | illness, such as schizophrenia, bipolar disorder, severe | ||||||
| 4 | depression, or gastrointestinal disorders that include | ||||||
| 5 | gastroparesis, nausea, and vomiting, require treatment with | ||||||
| 6 | medications that work as dopamine receptor blocking agents | ||||||
| 7 | (DRBAs), including antipsychotics; and
| ||||||
| 8 | WHEREAS, While ongoing treatment with these medications | ||||||
| 9 | can be very helpful, even lifesaving, for many people, it can | ||||||
| 10 | also lead to Tardive Dyskinesia (TD); and
| ||||||
| 11 | WHEREAS, Tardive Dyskinesia is a movement disorder that is | ||||||
| 12 | characterized by random, involuntary, and uncontrolled | ||||||
| 13 | movements of different muscles in the face, trunk, and | ||||||
| 14 | extremities; and
| ||||||
| 15 | WHEREAS, Tardive Dyskinesia can develop months, years, or | ||||||
| 16 | decades after a person starts taking DRBAs and even after they | ||||||
| 17 | have discontinued use of those medications; not everyone who | ||||||
| 18 | takes a DRBA develops TD, but if it develops, it is often | ||||||
| 19 | permanent; and
| ||||||
| 20 | WHEREAS, It is estimated that over 500,000 Americans | ||||||
| 21 | suffer from Tardive Dyskinesia; according to the National | ||||||
| |||||||
| |||||||
| 1 | Alliance for Mental Illness, one in every four patients | ||||||
| 2 | receiving long-term treatment with an antipsychotic medication | ||||||
| 3 | will experience Tardive Dyskinesia; and
| ||||||
| 4 | WHEREAS, Years of difficult and challenging research have | ||||||
| 5 | resulted in recent scientific breakthroughs, with two new | ||||||
| 6 | treatments for Tardive Dyskinesia approved by the United | ||||||
| 7 | States Food and Drug Administration; and
| ||||||
| 8 | WHEREAS, Tardive Dyskinesia is often unrecognized, and | ||||||
| 9 | patients suffering from the illness are commonly misdiagnosed; | ||||||
| 10 | regular screening for TD in patients taking DRBA medications | ||||||
| 11 | is recommended by the American Psychiatric Association (APA); | ||||||
| 12 | therefore, be it
| ||||||
| 13 | RESOLVED, BY THE SENATE OF THE ONE HUNDRED SECOND GENERAL | ||||||
| 14 | ASSEMBLY OF THE STATE OF ILLINOIS, that we declare the week of | ||||||
| 15 | May 2, 2021 as "Tardive Dyskinesia Awareness Week" in the | ||||||
| 16 | State of Illinois; and be it further
| ||||||
| 17 | RESOLVED, That we encourage every individual in the United | ||||||
| 18 | States to become better informed about and aware of Tardive | ||||||
| 19 | Dyskinesia.
| ||||||
